Masimo Corp. Stock
Masimo Corp. Stock
A loss of -2.460% shows a downward development for Masimo Corp..
We see a rather positive sentiment for Masimo Corp. with 7 Buy predictions and 1 Sell predictions.
As a result the target price of 147 € shows a positive potential of 30.09% compared to the current price of 113.0 € for Masimo Corp..
Pros and Cons of Masimo Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Masimo Corp. | -2.460% | -11.059% | -12.741% | -28.908% | 6.153% | -36.783% | - |
Neogen Corp. | -3.510% | -0.901% | -6.780% | -27.632% | -39.891% | -71.975% | -59.402% |
Bio-Rad Labs Inc. A | 3.230% | 0.615% | -14.995% | -21.774% | -10.797% | -47.410% | - |
Merit Medical Systems | -1.360% | -0.685% | 9.023% | -5.229% | 6.618% | 38.095% | 44.394% |
Comments
Masimo Co. (NASDAQ: MASI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $170.00 price target on the stock, up previously from $148.00.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $160.00 price target on the stock, up previously from $117.00.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at BTIG Research from $145.00 to $166.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat